Skip to content

effect of dexmedetomidine in inducing and maintaining cardiac surgery anesthesia

Evaluating the effect of using dexmedetomidine in inducing and maintaining anesthesia in cardiac surgery patients

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240624062233N1
Enrollment
70
Registered
2024-06-26
Start date
2024-06-28
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac surgeries including coronary artery bypass surgery with a pump, valve replacement surgery, and valve repair surgery.

Interventions

Intervention 1: Intervention group: 0.5 mcg/kg/hr of dexmedetomidine infusion, midazolam 0.1-0.2 mg/kg/hr, and sufentanil: 3-5 mcg /kg/hr infusion according to patient situation. Intervention 2: Contr

Sponsors

Gorgan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients aged between 18-65 years both sexes male and female Patients under one of these surgery (pump coronary artery bypass surgery- valvular replacement surgery- valvular repair surgery) Informed consent to participate in the study

Exclusion criteria

Exclusion criteria: Patient with one of these diseases (serious coagulopathy- inflammatory diseases- immunosuppressive and immunomodulatory agents(DMARDs)- with history of arrhythmia- with chronic renal failure- Psychiatric diseases- with history of seizure- with history of rheumatic disorders) Patient uses these medicines (steroids- non-steroidal anti-inflammatory drugs (NSAD) except ASA < ?? mg/day- thrombolytic agent) Patient with more the one surgical procedure at the same time. Alcoholic patient Patient need more than one valve repair

Design outcomes

Primary

MeasureTime frame
The amount of change in hemodynamic responses (heart rate, blood pressure, mean arterial pressure). Timepoint: Before and after surgery. Method of measurement: electrocardiogram to measure the heart rate and rhythm monitoring of non-invasive blood pressure, and end-tidal carbon dioxide (capnograph) to measure the paco.

Secondary

MeasureTime frame
Inflammatory factors (IL1, IL6, IL13, IL18). Timepoint: before surgery and ?? hours after surgery. Method of measurement: Blood gas analysis.;Lactate level. Timepoint: before, during and after surgery according to following: before induction during induction pre pump, after sternotomy pump?, pump?, pump?, pump off and after closing the ternum. Method of measurement: Blood gas analysis.;Post-operative recovery time. Timepoint: after surgery. Method of measurement: Retention time in recovery room in hours.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Ali Jabbari

Gorgan University of Medical Sciences

amir_a_78@yahoo.com+98 17 3220 2154

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026